Searched for
LUPIN FINANCIAL RESULTS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Stocks in news: HDFC Bank, ICICI Bank, RIL, Trent, Jio FinancialIndian markets are set for a dynamic start today. Investors will closely watch the Q4 results from banking giants HDFC Bank and ICICI Bank....
- Lupin shares jump 2% as Q2 PAT soars 73% YoY to Rs 1,485 croreLupin shares rose on Friday after the pharma major reported a robust 73% YoY surge in Q2 FY26 PAT to Rs 1,485 crore, driven by strong sales...
- Lupin shares in focus after Q1 profit jumps 52% YoY to Rs 1,221 croreLupin's shares are in focus following a robust Q1 performance, with net profit surging 52% to Rs 1,221 crore, fueled by strong US and India...
- Stocks to buy today: Motilal Oswal retains buy on LT Foods; Nuvama sees over 20% upside in LupinJM Financial has maintained its Buy rating on Crompton Greaves Consumer, emphasizing the company's entry into the solar rooftop segment and...
- Stocks in news: TCS, Tata Elxsi, Lupin, Hindalco, Tata MotorsAdvait Energy Transitions received letter of intent (LoI) from Gujarat Urja Vikas Nigam for setting up of a 50 MW out of 500 MW/1000 MWh st...
- An old hand’s back, but can Lupin and he make it count?Now that Swaminathan is back, Lupin’s shareholders may expect improvement in the company’s performance.
- Lupin nosedives 8% even as drugmaker reports 47% PAT growth in Q4The company had reported PAT of Rs 547 crore in the same quarter last financial year.
- It may take another quarter for Lupin to post a robust showMumbaibased pharma company Lupin has posted better-than-expected numbers after reporting dismal figures for four successive quarters.
- Pharma stocks unlikely to lead next leg of rally: Deepak ShenoySome midcap pharma companies though have come up with encouraging numbers, but overall this is a time to step back, says Shenoy.
- Lupin falls on lower sales guidance for FY16Lupin’s move to acquire Gavis Pharmaceuticals for $880 million, approximately Rs 5600 crore, is seen as a long-term positive.
- Government allows Lupin to hike FII limit cap to 49 per centThe proposal was cleared in the meeting of the Cabinet Committee on Economic Affairs (CCEA) headed by Prime Minister Narendra Modi.
- Why Lupin isn't reacting to alliance with Merck SeronoWhen the company announced long-term strategic partnership with Merck Serono (MS), the biopharmaceutical division of Merck, the stock came ...
- Preview: Lupin PAT seen up 4% YoY; higher input cost to dent marginsAccording to ET NOW, domestic formulations business is likely to grow by 20-23 per cent while the exports may see growth of 35 per cent. Hi...
- Lupin gets FDA nod for Levetiracetam TabletsDomestic drug maker Lupin on Friday announced that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has received the final approval for...
- Lupin to announce Q2 results on Oct 19Pharma company Lupin Ltd on Thursday said it will announce unaudited financial results for the quarter ending September 30, on October 19.
Load More
